Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Marker Therapeutics Inc (NQ: MRKR )

2.710 +0.220 (+8.84%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,873
Open 2.520
Bid (Size) 2.630 (1)
Ask (Size) 2.850 (1)
Prev. Close 2.490
Today's Range 2.510 - 2.780
52wk Range 2.400 - 6.157
Shares Outstanding 8,922,695
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MRKR Stock Earnings: Marker Therapeutics Beats EPS for Q2 2024
MRKR stock results show that Marker Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
MRKR Stock Earnings: Marker Therapeutics Reported Results for Q4 2023
Marker Therapeutics just reported results for the fourth quarter of 2023. 
Via InvestorPlace

Performance

YTD
-50.37%
-50.37%
1 Month
+0.37%
+0.37%
3 Month
-51.35%
-51.35%
6 Month
-38.96%
-38.96%
1 Year
-18.13%
-18.13%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
MRKR Stock Earnings: Marker Therapeutics Reported Results for Q1 2024
Via InvestorPlace
Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
What's Going On With Marker Therapeutics (MRKR) Stock
Via Benzinga
Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 12/11
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?
Via Benzinga
Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies
Via Newsfile
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 7/24
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Marker Therapeutics (MRKR) Stock Is Trading Sharply Higher
Via Benzinga
Nasdaq Gains 1%; US Budget Deficit Widens In May
Via Benzinga
Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.